Selected Serum Biomarkers in Patients with Relapsing-Remitting Multiple Sclerosis—A 3-Year Prospective Pilot Study
Serum levels of NFL, osteopontin, and occludin may serve as biomarkers of disease activity in patients with RRMS. The clinical relevance of these biomarkers should be confirmed through repeated serum marker assessments in MS patients and validation studies involving larger sample sizes.
Authors
- Anetta Lasek‐Bal (ORCID: https://orcid.org/0000-0003-2481-7528)
- Katarzyna Maciejowska (ORCID: https://orcid.org/0000-0003-2636-5115)
- Małgorzata A. Janik (ORCID: https://orcid.org/0000-0001-5489-4220)
- Daria Gendosz de Carrillo (ORCID: https://orcid.org/0000-0001-5090-8365)
- Przemysław Puz (ORCID: https://orcid.org/0000-0002-7787-5660)
Institutions
- Medical University of Silesia (PL)
- University of Silesia in Katowice (PL)
Publication Details
- Journal
- Medical Sciences
- Published
- 2025-11-25
- DOI
- https://doi.org/10.3390/medsci13040283
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Agencja Badań Medycznych